Table 2 : Health care characteristics of survey respondents (N=100).


  Total Have Participated Have Not Participated

  N=100 % N=35 % N=34 %

Healthcare specialty

Oncology 43 47.8 19 55.9 10 32.3
Non-oncology 47 52.2 15 44.1 21 67.7

Oncology specialty            

Medical Oncology 28 65.1 11 57.9 7 70.0
Pediatric Oncology 2 4.7 0 0.0 1 10.0
Radiation Oncology 5 11.6 2 10.5 1 10.0
Surgical Oncology 8 18.6 6 31.6 1 10.0

Amount of offices

Zero, does not see
patients
20 22.7 3 8.8 5 16.7
One 50 56.8 21 61.8 21 70.0
Two or more 18 20.5 10 29.4 4 13.3

Type of medical community

Urban 29 33.3 14 41.2 9 28.1
Suburban 38 43.7 12 35.3 15 46.9
Rural 12 13.8 6 17.6 5 15.6
Combination of urban, suburban,
and rural
8 9.2 2 5.9 3 9.4

Length of practice

5 years or less 10 12.3 5 15.2 5 16.7
6 to 20 years 22 27.2 6 18.2 12 40.0
More than 20 years 49 60.5 22 66.7 13 43.3

Does respondent find that there are barriers to their participation in clinical research?

Yes 38 59.4 21 61.8 17 56.7
No 26 40.6 13 38.2 13 43.3

Types of Barriers (reported by those who answered yes above; select all that apply)

Lack of access 17 44.7 10 47.6 7 41.2
Infrastructural needs 18 47.4 13 61.9 5 29.4
Lack of experience 15 39.5 5 23.8 10 58.8
Personnel needs 22 57.9 15 71.4 7 41.2
Time constraints 23 60.5 13 61.9 10 58.8
Incentives not worth the effort 11 28.9 9 42.9 2 11.8
Patients are unwilling 8 21.1 2 9.5 6 35.3

Jandorf et al.Journal of Cancer Therapeutics and Research  2016 5:3DOI : 10.7243/2049-7962-5-3